Cargando…
Curcumin: A Novel Way to Improve Quality of Life for Colorectal Cancer Patients?
Colorectal cancer (CRC) is the third most common cancer in men and the second most common in women. Treatment of metastatic CRC consists of highly toxic chemotherapeutic drug combinations that often negatively affect patient quality of life (QoL). Moreover, chemotherapy-induced toxicity and chemothe...
Autores principales: | Layos, Laura, Martínez-Balibrea, Eva, Ruiz de Porras, Vicenç |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695864/ https://www.ncbi.nlm.nih.gov/pubmed/36430537 http://dx.doi.org/10.3390/ijms232214058 |
Ejemplares similares
-
Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway
por: Ruiz de Porras, Vicenç, et al.
Publicado: (2016) -
PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines
por: Ginés, Alba, et al.
Publicado: (2015) -
Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients
por: Ruiz de Porras, Vicenç, et al.
Publicado: (2019) -
Natural bioactive compounds: a potential therapeutic strategy to sensitize bladder cancer to cisplatin treatment?
por: Ruiz de Porras, Vicenç
Publicado: (2022) -
Macrophages as a Therapeutic Target in Metastatic Prostate Cancer: A Way to Overcome Immunotherapy Resistance?
por: Martori, Clara, et al.
Publicado: (2022)